Greg Zante
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Viking Therapeutics, Inc. (VKTX)
Source not stated
Current -
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Viking Therapeutics, Inc. (VKTX) | Chief Financial Officer | $521,000 | $5,135,872 |
| 2024 | Viking Therapeutics, Inc. (VKTX) | Chief Financial Officer | $475,000 | $4,681,394 |
| 2023 | Viking Therapeutics, Inc. (VKTX) | Chief Financial Officer | $455,000 | $3,495,957 |
| 2022 | Viking Therapeutics, Inc. (VKTX) | Chief Financial Officer | $425,000 | $1,710,661 |
| 2021 | Viking Therapeutics, Inc. (VKTX) | Chief Financial Officer | $400,000 | $1,345,330 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.